Sort by
Refine Your Search
-
Category
-
Field
-
with a PhD in molecular and cellular biology, obtained during the past four years. Selection process Applications will be accepted through early September 2026. Interviews with selected candidates will
-
the Cancer Epigenetics and Immunotherapy group headed by Dr Pilar Dominguez at the Mediterranean Center for Molecular Medicine (C3M) INSERM U1065 - Université Côte d’Azur in Nice https://www.c3m-nice.fr/en
-
junior professor, the “Chaire” will be engaged in the training of young scientists and medical doctors through the advanced programs at Sorbonne Paris Nord University. This will facilitate the development
-
tenure in the Inserm Research Directors personnel at the end of the contract. Strategy of the host institution: The French National Institute for Health and Medical Research (INSERM) is the primary public
-
tenure in the Inserm Research Directors personnel at the end of the contract. Strategy of the host institution: The French National Institute for Health and Medical Research (INSERM) is the primary public
-
selected at the end of the selection process will be offered a researcher contract, following approval from the President and CEO of Inserm. Required profile: Education Level: Phd Researcher Profile: R3/R4
-
. The candidates selected at the end of the selection process will be offered a researcher contract, following approval from the President and CEO of Inserm. Required profile: Education Level: Phd Researcher Profile
-
personnel at the end of the contract. Strategy of the host institution: The French National Institute for Health and Medical Research (INSERM) is the primary public institution dedicated to biomedical and
-
. The candidates selected at the end of the selection process will be offered a researcher contract, following approval from the President and CEO of Inserm. Required profile: Education Level: Phd Researcher Profile
-
tenure in the Inserm Research Directors personnel at the end of the contract. Strategy of the host institution: The French National Institute for Health and Medical Research (INSERM) is the primary public